A detailed history of Private Wealth Management Group, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Private Wealth Management Group, LLC holds 41 shares of VRTX stock, worth $18,392. This represents 0.01% of its overall portfolio holdings.

Number of Shares
41
Previous 34 20.59%
Holding current value
$18,392
Previous $14.2 Million 35.21%
% of portfolio
0.01%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$392.81 - $485.53 $2,749 - $3,398
7 Added 20.59%
41 $19.2 Million
Q4 2023

Feb 08, 2024

BUY
$343.0 - $410.68 $11,662 - $13,963
34 New
34 $13.8 Million

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $115B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Private Wealth Management Group, LLC Portfolio

Follow Private Wealth Management Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Private Wealth Management Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Private Wealth Management Group, LLC with notifications on news.